Equities
  • Price (EUR)148.96
  • Today's Change-1.76 / -1.17%
  • Shares traded5.00
  • 1 Year change-20.49%
  • Beta1.1047
Data delayed at least 15 minutes, as of Feb 06 2026 16:25 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Cochlear Limited provides implantable hearing solutions and a range of implants and sound processor upgrades. Its segments include Cochlear Implants, Services, and Acoustics. The Cochlear Implants segment offers Cochlear implant systems. The Services segment offers sound processor upgrades, accessories and other. The Acoustics segment offers bone conduction systems and sound processor upgrades. Its products and services portfolio includes Cochlear implant portfolio, Acoustic solutions portfolio, Recipient support tools, and Cochlear Connected Care solutions. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check. Its Cochlear implant portfolio includes Cochlear Nucleus System. Acoustic solutions portfolio includes Cochlear Osia System, and Cochlear Baha System. Its Recipient support tools include Cochlear Nucleus, and Baha and Osia Smart Apps.

  • Revenue in AUD (TTM)2.34bn
  • Net income in AUD388.90m
  • Incorporated1983
  • Employees5.50k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.